United Kingdom · Question · Written question
UIN 66175
Fibrodysplasia Ossificans Progressiva: Drugs
Introduced
29 October 2021
Last action
5 November 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
5 November 2021
Summary
To ask the Secretary of State for Health and Social Care, pursuant to the Answers of 22 October 2021 to Questions 56489 and 56878, on Fibrodysplasia Ossificans Progressiva: Health Services, what the status is of the highly specialised technologies guidanc
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
29 October 2021
Written question
To ask the Secretary of State for Health and Social Care, pursuant to the Answers of 22 October 2021 to Questions 56489 and 56878, on Fibrodysplasia Ossificans Progressiva: Health Services, what the status is of the highly specialised technologies guidanc
Source: Commons
5 November 2021
Answer
The National Institute for Health and Care Excellence is in the early stages of developing highly specialised technologies guidance on palovarotene and is in discussion with the manufacturer regarding timings for this appraisal. The publication date for g...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-10-29/66175
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1364640
- uk · wq-1364640 · source updated 5 November 2021